Status:
UNKNOWN
Longitudinal Study of Multi-Analyte Profile for Dyslipidemia
Lead Sponsor:
MaiHealth Inc
Conditions:
Dyslipidemia
Eligibility:
All Genders
30-65 years
Phase:
NA
Brief Summary
The primary objective of this study is to determine any changes in cardiovascular risk among individuals receiving a statin by assessing their multi-analyte profile.
Detailed Description
Over the past decade there has been a growing debate about the clinical value content of a single individual diagnostic indicator of disease onset, progression or therapeutic intervention. In particul...
Eligibility Criteria
Inclusion
- Sign and Date IRB approved consent form
- Be between 30-65 years of age as of date of consent
- Have a total cholesterol value of 200-300 (units)
- Have an LDL cholesterol value of \> 100 (units)
- Able to speak and understand English
- Willing and able to participate for the 6 months required by the study
- Willing and able to provide fasting blood specimens
- Women of child-bearing potential must have a negative pregnancy test at screening
- Medically (appropriate) eligible to take the statin as determined by PI
Exclusion
- Have a body Mass Index (BMI) \> or = 35
- Pregnant (or planning to become pregnant during the course of the study)
- Currently taking a statin or discontinued taking a statin within 9 months of the date of screening
Key Trial Info
Start Date :
June 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2012
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01441908
Start Date
June 1 2011
End Date
April 1 2012
Last Update
April 16 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wake Research Associates
Raleigh, North Carolina, United States, 27617